SCHEMBL9348257

SCHEMBL9348257

CC(C)CCCCCc1cccc(C(C)(C)C)c1O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 P00918 1/20 0.47
GABRA1 P14867 3/20 0.42
GABRB2 P47870 3/20 0.42
ATM Q13315 1/20 0.39
ALOX5 P09917 1/20 0.38
PTGS2 P35354 1/20 0.38
ALOX12 P18054 1/20 0.36
ALDH1A1 P00352 1/20 0.34
TSHR P16473 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
BID P55957 3/20 0.33
MCL1 Q07820 3/20 0.33
BCL2L1 Q07817 2/20 0.33
BAK1 Q16611 2/20 0.33
KAT8 Q9H7Z6 2/20 0.33
HIF1A Q16665 1/20 0.33
EPAS1 Q99814 1/20 0.33
TYR P14679 1/20 0.33
CYP1A2 P05177 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9348366 0.87 CA2 (0.53) CA2GABRA1GABRB2ATMALOX12
SCHEMBL5615700 0.85 GABRA1 (0.53) GABRA1GABRB2ALOX5PTGS2BID
SCHEMBL27745672 0.85 GABRA1 (0.53) GABRA1GABRB2ALOX5PTGS2BID
SCHEMBL9351889 0.83 GABRA1 (0.57) GABRA1GABRB2ALOX5PTGS2BID
SCHEMBL9352402 0.83 ALOX5 (0.55) CA2GABRA1GABRB2ALOX5PTGS2
SCHEMBL6568762 0.83 CA2 (0.52) CA2GABRA1GABRB2ATMALOX5
SCHEMBL6568673 0.83 CA2 (0.52) CA2GABRA1GABRB2ATMALOX5
SCHEMBL28387663 0.83 ALOX5 (0.55) CA2GABRA1GABRB2ALOX5PTGS2
SCHEMBL8326910 0.83 ALOX5 (0.55) CA2GABRA1GABRB2ALOX5PTGS2
SCHEMBL11021636 0.83 ALOX5 (0.55) CA2GABRA1GABRB2ALOX5PTGS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0258598-B1 N-(substituted-1-piperazinealkyl)-alpha-(3,5-di-alkyl-4-hydroxyphenyl)-alpha,alpha-dialkyl acetamides GOODRICH CO B F (US) 1994-09-07 EP disclosed
CN-1022915-C Process for preparing N, alpha-substituted acetamide GOODRICH CO B F (US) 1993-12-01 CN disclosed
EP-0253010-B1 N-(SUBSTITUTED CYCLIC ALKYLENEIMINE)-ALPHA-(3,5-DI-ALKYL-4-HYDROXY-PHENYL)-ALPHA, ALPHA-DIALKYL ACETAMIDES The B.F. GOODRICH Company (US) 1992-12-02 EP disclosed
US-5096949-A Heat and oxidation resistance, photostability; polyolefins; uv rad THE B. F. GOODRICH COMPANY (US) 1992-03-17 US disclosed
US-4920228-A N,N-disubstituted, α-(3,5-dialkyl-4-hydroxyphenyl)-α,α-disubstituted acetamides and composition stabilized therewith THE B. F. GOODRICH COMPANY (US) 1990-04-24 US disclosed
US-4780495-A HEAT, OXIDATION, AND LIGHT STABILIZERS THE B. F. GOODRICH COMPANY (US) 1988-10-25 US disclosed
EP-0284800-A1 N-(substituted piperidinyl)-alpha-(3,5-dialkyl-4-hydroxyphenyl)-alpha', alpha''-dialkyl acetamides THE B.F. GOODRICH COMPANY (US) 1988-10-05 EP disclosed
CN-88101131-A N- (substituted cyclic alkylideneimino) -X- (3, 5-dialkyl-4-hydroxyphenyl) -X ', X' -dialkylacetamide GOODRICH CO B F (US) 1988-09-14 CN disclosed
EP-0141419-B1 3,5-DIALKYL-4-HYDROXYPHENYL-SUBSTITUTED DERIVATIVES The B.F. GOODRICH Company (US) 1988-03-09 EP disclosed
EP-0258598-A2 N-(substituted-1-piperazinealkyl)-alpha-(3,5-di-alkyl-4-hydroxyphenyl)-alpha,alpha-dialkyl acetamides THE B.F. GOODRICH COMPANY (US) 1988-03-09 EP disclosed
EP-0253010-A1 N-(substituted cyclic alkyleneimine)-alpha-(3,5-di-alkyl-4-hydroxy-phenyl)-alpha, alpha-dialkyl acetamides The B.F. GOODRICH Company (US) 1988-01-20 EP disclosed
US-4523032-A 3,5-Dialkyl-4-hydroxyphenyl-substituted acetic acids THE B. F. GOODRICH COMPANY (US) 1985-06-11 US disclosed
EP-0141419-A1 3,5-Dialkyl-4-hydroxyphenyl-substituted derivatives The B.F. GOODRICH Company (US) 1985-05-15 EP disclosed